Status:
COMPLETED
Feasibility Study of the NEW NORMA-SENSE
Lead Sponsor:
Carmel Medical Center
Collaborating Sponsors:
Lin Medical Center, Haifa
Common Sense
Conditions:
Vaginal Infection
Eligibility:
FEMALE
18-45 years
Brief Summary
* In-vitro study * Collect data regarding the color appearance on the new developed indicator strips (NEW NORMA-SENSE), in contact with vaginal secretion with elevated pH * Measure the buffering capac...
Detailed Description
This in-vitro study was designed to collect data regarding the color appearance on the new developed indicator strips (NEW NORMA-SENSE) when coming in contact, in-vitro, with vaginal secretion with el...
Eligibility Criteria
Inclusion
- Women, aged between 18 and 45, with or without symptoms of vaginal infection.
- Subjects are ready to sign the informed consent form.
Exclusion
- Subjects are unable or unwilling to cooperate with the study procedures.
- Subjects are currently participating in another clinical study that may directly or indirectly affect the results of this study.
- Subjects that suffer from vaginal bleeding or menstruate.
- Subjects that have had sexual relations within the last 12 hours.
- Subjects that applied local antiseptic, antibiotic or vaginal treatment within the last 3 days.
- Subjects that applied vaginal douching within 12 hours prior to the visit at the clinic.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00324246
Start Date
September 1 2006
End Date
December 1 2007
Last Update
June 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Care Center - Lin Medical Center
Haifa, Israel